insurance changes to glp 1 drugs How Afford GLP-1s in 2026: What to Know About Coverage and Alternative Options Major insurance changes are coming

M., Alotaibi, W

These patients had been diabetic for about 2.5 years and only about 15% of patients had ever been on a medication to treat their diabetes, these were truly treatment naive patients

But a growing body of research, and a wave of real-world experience, suggests these drugs may have meaningful benefits for people with T1D too: lower daily insulin doses, flatter glucose curves on your CGM, and potentially better long-term protection for your heart and kidneys

The brand name confusion problem: why semaglutide has three names Semaglutide exists under three FDA-approved brand names: Ozempic: 0.25 mg, 0.5 mg, 1 mg, 2 mg doses for type 2 diabetes Wegovy: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg doses for obesity Rybelsus: 3 mg, 7 mg, 14 mg oral tablets for type 2 diabetes The active ingredient is identical

Insurers needed solutions that worked within the fiscal year, not across decades